PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its ...

Sanofi said its Opella business has been valued at around 16 billion euros (USD17.38 billion), or 14 times EBITDA in 2024 ...

Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, ...

A stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of ...

US private equity firm CD&R has agreed to French government demands seeking to protect jobs and investment in France.

Sanofi and Sudair Pharma Company (SPC) have joined forces to establish a state-of ... Our team, across some 100 countries, is ...

Sanofi said on Monday it had entered exclusive talks for the sale of a 50% controlling stake in its consumer health business ...

The breakthrough came after the investment group provided France with guarantees on maintaining jobs and production in the ...

Sanofi, which is joining a growing number of drugmakers shedding consumer related businesses, said Opella had been valued at ...

The gift will be spread over 10 years and divided among Morehouse, Howard University College of Medicine and Meharry Medical ...

Sanofi & Orano join forces to accelerate the development of develop next-generation radioligand medicines: Paris Friday, October 18, 2024, 10:00 Hrs [IST] Sanofi and Orano Med, a ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...